ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
100 hedge funds and large institutions have $106M invested in Endocyte, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 36 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
28% less call options, than puts
Call options by funds: $1.88M | Put options by funds: $2.61M
Holders
100
Holding in Top 10
–
Calls
$1.88M
Puts
$2.61M
Top Buyers
| 1 | +$2.68M | |
| 2 | +$2.59M | |
| 3 | +$1.81M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$989K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$924K |
Top Sellers
| 1 | -$4.16M | |
| 2 | -$1.89M | |
| 3 | -$1.38M | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$1.32M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$815K |